BamSEC and AlphaSense Join Forces
Learn More

Arcus Biosciences Inc. – Indentures

NYSE: RCUS    
Share price (6/29/26): $31.08    
Market cap (6/29/26): $3.909 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.4
from S-3ASR 52 pages Arcus Biosciences, Inc. Indenture Dated as of , 20___ [ ] Trustee
12/34/56
EX-4.9
from S-3ASR 17 pages Arcus Biosciences, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Arcus Biosciences, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.8
from S-3ASR 17 pages Arcus Biosciences, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Arcus Biosciences, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.3
from 10-K 2 pages Arcus Biosciences, Inc. Description of Common Stock
12/34/56
EX-4.02
from 10-K 3 pages Arcus Biosciences, Inc. Description of Common Stock
12/34/56
EX-4.8
from S-3 18 pages Arcus Biosciences, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Arcus Biosciences, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.7
from S-3 21 pages Arcus Biosciences, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Arcus Biosciences, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.6
from S-3 21 pages Arcus Biosciences, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Arcus Biosciences, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.4
from S-3 55 pages Arcus Biosciences, Inc, Issuer and [Trustee], Trustee Indenture Dated as of [ • ], 20__ Debt Securities
12/34/56
EX-4.1
from S-1 52 pages Arcus Biosciences, Inc. Amended and Restated Investors’ Rights Agreement November 3, 2017
12/34/56